89 related articles for article (PubMed ID: 10091728)
61. Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer.
Zeestraten EC; Maak M; Shibayama M; Schuster T; Nitsche U; Matsushima T; Nakayama S; Gohda K; Friess H; van de Velde CJ; Ishihara H; Rosenberg R; Kuppen PJ; Janssen KP
Br J Cancer; 2012 Jan; 106(1):133-40. PubMed ID: 22108518
[TBL] [Abstract][Full Text] [Related]
62. A new cancer diagnostic system based on a CDK profiling technology.
Ishihara H; Yoshida T; Kawasaki Y; Kobayashi H; Yamasaki M; Nakayama S; Miki E; Shohmi K; Matsushima T; Tada S; Torikoshi Y; Morita M; Tamura S; Hino Y; Kamiyama J; Sowa Y; Tsuchihashi Y; Yamagishi H; Sakai T
Biochim Biophys Acta; 2005 Sep; 1741(3):226-33. PubMed ID: 15990281
[TBL] [Abstract][Full Text] [Related]
63. Pneumocystis carinii modulates cyclin-dependant kinase activity in a lung epithelial cell line.
Anders RA; Gustafson M; Edens M; Limper AH; Leof EB
J Eukaryot Microbiol; 1996; 43(5):13S. PubMed ID: 8822821
[No Abstract] [Full Text] [Related]
64. Cellular substrates of p34(cdc2) and its companion cyclin-dependent kinases.
Nigg EA
Trends Cell Biol; 1993 Sep; 3(9):296-301. PubMed ID: 14731846
[TBL] [Abstract][Full Text] [Related]
65. A tale of two clocks: phosphorylation of NICD by CDKs links cell cycle and segmentation clock.
Braunreiter KM; Cole SE
EMBO Rep; 2019 Jul; 20(7):e48247. PubMed ID: 31267704
[TBL] [Abstract][Full Text] [Related]
66. Plasmodium cdc2-related kinases: Do they regulate stage differentiation?
Kinnaird JH; Mottram JC
Parasitol Today; 1997 Jan; 13(1):7-8; discussion 38-9. PubMed ID: 15275159
[No Abstract] [Full Text] [Related]
67. MicroRNA-195 suppresses colorectal cancer cells proliferation via targeting FGF2 and regulating Wnt/β-catenin pathway.
Zhang X; Xu J; Jiang T; Liu G; Wang D; Lu Y
Am J Cancer Res; 2016; 6(11):2631-2640. PubMed ID: 27904776
[TBL] [Abstract][Full Text] [Related]
68. Effect of the WWOX gene on the regulation of the cell cycle and apoptosis in human ovarian cancer stem cells.
Yan H; Tong J; Lin X; Han Q; Huang H
Mol Med Rep; 2015 Aug; 12(2):1783-8. PubMed ID: 25891642
[TBL] [Abstract][Full Text] [Related]
69. CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity.
Bonelli P; Tuccillo FM; Borrelli A; Schiattarella A; Buonaguro FM
Biomed Res Int; 2014; 2014():361020. PubMed ID: 24605326
[TBL] [Abstract][Full Text] [Related]
70. Three meta-analyses define a set of commonly overexpressed genes from microarray datasets on astrocytomas.
Liu Z; Xie M; Yao Z; Niu Y; Bu Y; Gao C
Mol Neurobiol; 2013 Feb; 47(1):325-36. PubMed ID: 23135747
[TBL] [Abstract][Full Text] [Related]
71. Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation by multiple oncogenic pathways.
Horiuchi D; Huskey NE; Kusdra L; Wohlbold L; Merrick KA; Zhang C; Creasman KJ; Shokat KM; Fisher RP; Goga A
Proc Natl Acad Sci U S A; 2012 Apr; 109(17):E1019-27. PubMed ID: 22474407
[TBL] [Abstract][Full Text] [Related]
72. Cdk1, Plks, Auroras, and Neks: the mitotic bodyguards.
Salaun P; Rannou Y; Prigent C
Adv Exp Med Biol; 2008; 617():41-56. PubMed ID: 18497029
[No Abstract] [Full Text] [Related]
73. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer.
Vermeulen K; Van Bockstaele DR; Berneman ZN
Cell Prolif; 2003 Jun; 36(3):131-49. PubMed ID: 12814430
[TBL] [Abstract][Full Text] [Related]
74. Activation of cyclin E-dependent kinase activity in colorectal cancer.
Cam WR; Masaki T; Shiratori TY; Kato N; Okamoto M; Yamaji Y; Igarashi K; Sano T; Omata M
Dig Dis Sci; 2001 Oct; 46(10):2187-98. PubMed ID: 11680595
[TBL] [Abstract][Full Text] [Related]
75. Amplified CDK2 and cdc2 activities in primary colorectal carcinoma.
Kim JH; Kang MJ; Park CU; Kwak HJ; Hwang Y; Koh GY
Cancer; 1999 Feb; 85(3):546-53. PubMed ID: 10091728
[TBL] [Abstract][Full Text] [Related]
76. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
77. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma.
Sasano H; Frost AR; Saitoh R; Taniyama Y; Nagura H; Matsunaga G; Takehana K; Kimura M; Silverberg SG
Anticancer Res; 1997; 17(5A):3685-90. PubMed ID: 9413224
[TBL] [Abstract][Full Text] [Related]
78. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
79. Differential and dramatic changes of cyclin-dependent kinase activities in cardiomyocytes during the neonatal period.
Kang MJ; Koh GY
J Mol Cell Cardiol; 1997 Jul; 29(7):1767-77. PubMed ID: 9236132
[TBL] [Abstract][Full Text] [Related]
80. [RB gene expression in gastrointestinal tract].
Monden T; Yamamoto H; Ikeda K; Izawa H; Tsujie M; Ohnishi T; Miyoshi Y; Sekimoto M; Tomita N; Monden M
Nihon Rinsho; 1996 Apr; 54(4):965-71. PubMed ID: 8920658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
